Nevertheless, in the absence of a clear mammalian substrate for DNAJB6, these findings with its closest yeast homolog Sis1 and the impact of the LGMDD1 mutants on client processing provide crucial mechanistic insight to begin to explore therapeutic routes for this myopathy. Here, DNAJB1 is linked to myopathy.